[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
About the Journal
Editorial Board
Keywords
For Authors::
Aims and Scope
Call for Papers
Submission Instructions
For Reviewers::
Referee page
Subscription::
Subscription Form
News & Events::
Journal News
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE
:: Volume 21, Issue 2 (4-2023) ::
Int J Radiat Res 2023, 21(2): 305-310 Back to browse issues page
Clinicopathological features and outcomes of 251 patients with esophageal cancer in the Eastern Anatolian Region of Turkey where upper gastrointestinal system tumors are endemic: Single-center data
D. Arslan , T. Koca , Z.A. Kaymak , M. Çevener , H. Başaran
Department of Medical  Oncology,  Erzurum  Regional  Training  and  Research  Hospital, Erzurum, Turkey , drsealion@hotmail.com
Abstract:   (975 Views)
Background: We aimed to report demographic features, tumor characteristics, and survival outcomes of the patients with esophageal cancer (EC) in the Eastern Anatolian Region of Turkey, where upper gastrointestinal tumors are endemic. Materials and Methods: Our retrospective investigation was performed on patients with EC treated in Erzurum Regional Training and Research Hospital Clinics of Medical and Radiation Oncology between 2005 and 2017. The patients with stage IIA-IV disease and completed at least one treatment modality (surgery/ definitive chemoradiotherapy(CRT)/palliative chemotherapy(CT) or radiotherapy(RT)) had enrolled in the study. The demographic and clinicopathological characteristics, TNM stage, oncological treatment modalities applied, and survival outcomes were statistically analyzed. Results: Our study consisted of 251(women, 57.4%) patients with EC with a female/male ratio of 1.34/1. The median age of the patients was determined as 62 years. The primary tumor was frequently localized in the middle(46.6%) and lower(46.2%) part of the esophagus, and the majority had squamous cell carcinoma histopathological subtype(86.1%). The median follow-up period and overall survival (OS) time were 21.2 and 19.0 months, respectively. A five-year OS rate was detected as 19.3%. As a result of multivariate analysis; grade, stage and concurrent CRT were determined as independent prognostic factors (p=0.004, p=0.019, and p=0.014, respectively). The median OS of stage II-III and IV patients were 25.79 versus 10.02 months (p<0.001). Among stage II-III patients, the best median OS was in the surgery+ adjuvan RT/CRT group(37.02 months). In stage IV patients, the median OS of female patients was found to be statistically significantly higher than that of males(15.77 versus 9.29 months p=0.007). Conclusion: EC is a significant health problem in the Eastern Anatolian Region of Turkey. Differences were detected according to age and gender, tumor characteristics, histological subtype, and disease stage rates in patients with EC living in this region, but the survival rate was similar with the literture. Surgery+ adjuvant RT/CRT provided better OS in the non-metastatic patients than other treatment modalities.
Keywords: Esophageal cancer, gastrointestinal system, chemoradiotherapy, endemic, survival.
Full-Text [PDF 665 kb]   (583 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
References
1. Ferlay J, Colombet M, Soerjomataram I, et al. (2018) Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer, 103: 356-387. [DOI:10.1016/j.ejca.2018.07.005] [PMID]
2. SEER. SEER Stats Facts Sheet (2020). Available from: https://seer.cancer.gov/statfacts/html/esoph.html
3. Jemal A, Siegel R, Ward E, et al. (2009) Cancer statistics CA Cancer J Clin, 59(4): 225-49. [DOI:10.3322/caac.20006] [PMID]
4. Blot WJ (1994) Esophageal cancer trends and risk factors. Semin Onco, 21(4): 403-410.
5. Sharma P and Sampliner RE (2001) The rising incidence of esophageal adenocarcinoma. Adv İntern Med, 46: 137-53.
6. van Hagen P, Hulshof MC, van Lanschot JJ, et al. (CROSS Group) (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med, 366(22): 2074-84. [DOI:10.1056/NEJMoa1112088] [PMID]
7. Cunningham D, Allum WH, Stenning SP, et al. (MAGIC Trial Participants) (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355(1): 11-20. [DOI:10.1056/NEJMoa055531] [PMID]
8. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin, 61(2): 69-90. [DOI:10.3322/caac.20107] [PMID]
9. Gholipour C, Shalchi RA, Abbasi M (2008) A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus, 21(4): 322-7. [DOI:10.1111/j.1442-2050.2007.00776.x] [PMID]
10. Tran GD, Sun XD, Abnet CC, Fan JH, et al. (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer, 113(3): 456-63. [DOI:10.1002/ijc.20616] [PMID]
11. Najafi F, Mozaffari HR, Karami M, et al. (2011) Trends in incidence of gastrointestinal tract cancers in Western iran, 1993-2007. Iran Red Crescent Med J, 13(11): 805-10.
12. Tepper J, Krasna MJ, Niedzwiecki D, et al. (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol, 26(7): 1086-92. [DOI:10.1200/JCO.2007.12.9593] [PMID] []
13. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. (CROSS study group) (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol, 16(9): 1090-1098. [DOI:10.1016/S1470-2045(15)00040-6]
14. Uyanıkoglu A, Binici DN, Coskun M (2011) Erzurum yöresi gastroskopi ve patoloji sonuçlarının değerlendirilmesi (Evaluation of gastroscopic and pathologic results Erzurum Region). Türkiye Klinikleri J Gastroenterohepatol, 18: 70-4.
15. Corley DA and Buffler PA (2001) Esophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer İncidance in Five Continents database. Int J Epidemiol, 30: 1415-1425. [DOI:10.1093/ije/30.6.1415] [PMID]
16. Dogan NB, Timur K, Hakan D (2009) Dietary Habits, Demographical, and Socio-economical Risk Factors of the Newly Diagnosed Gastric Cancers in the Eastern Anatolia Region of Turkey: An Endemic Upper Gastrointestinal Cancer Region. Dig Dis Sci, 54: 2629-2633. [DOI:10.1007/s10620-008-0647-6] [PMID]
17. Islami F, Boffetta P, Ren JS, Pedoeim L, et al. (2009) High-temperature beverages and foods and esophageal cancer risk--a systematic review. Int J Cancer, 125(3): 491-524. [DOI:10.1002/ijc.24445] [PMID] []
18. Islami F, Pourshams A, Nasrollahzadeh D, et al. (2009) Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ, 338: b929. [DOI:10.1136/bmj.b929] [PMID] []
19. Wu M, Liu AM, Kampman E, Zhang ZF, et al. (2009) Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer, 124(8): 1907-13. [DOI:10.1002/ijc.24142] [PMID]
20. Koca T, Arslan D, Basaran H, Cerkesli AK, et al. (2015) Dietary and demographical risk factors for oesophageal squamous cell carcinoma in the Eastern Anatolian region of Turkey where upper gastrointestinal cancers are endemic. Asian Pac J Cancer Prev, 16(5): 1913-7. [DOI:10.7314/APJCP.2015.16.5.1913] [PMID]
21. Mirinezhad SK, Somi MH, Seyednezhad F, et al. (2013) Survival in patients treated with definitive chemo- radiotherapy for non-metastatic esophageal cancer in north- west Iran. Asian Pac J Cancer Prev, 14(3): 1677-80. [DOI:10.7314/APJCP.2013.14.3.1677] [PMID]
22. Mansour-Ghanaei F, Heidarzadeh A, Naghipour MR, et al. (2012) A 10-year study of esophageal cancer in Guilan province, Iran: the Guilan Cancer Registry Study (GCRS). Asian Pac J Cancer Prev, 13(12): 6277-83. [DOI:10.7314/APJCP.2012.13.12.6277] [PMID]
23. Edge SB and Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17(6): 1471-4. [DOI:10.1245/s10434-010-0985-4] [PMID]
24. Siewert JR and Ott K (2007) Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol, 17(1): 38-44. [DOI:10.1016/j.semradonc.2006.09.007] [PMID]
25. Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst, 100(16): 1184-7. [DOI:10.1093/jnci/djn211] [PMID] []
26. Liu SZ, Wang B, Zhang F, Chen Q, et al. (2013) Incidence, survival and prevalence of esophageal and gastric cancer in Linzhou city from 2003 to 2009. Asian Pac J Cancer Prev, 14(10): 6031-4. [DOI:10.7314/APJCP.2013.14.10.6031] [PMID]
27. Mao WM, Zheng WH, Ling ZQ (2011) Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev, 12(10): 2461-6.
28. Glickman JN (2003) Section II: pathology and pathologic staging of esophageal cancer. Semin Thorac Cardiovasc Surg, 15(2): 167-79. https://doi.org/10.1016/S1043067903000182 [DOI:10.1016/S1043-0679(03)70025-2]
29. Chevallay M, Bollschweiler E, Chandramohan SM, et al. (2018) Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci, 1434(1): 132-138. [DOI:10.1111/nyas.13954] [PMID]
30. Gao XS, Qiao X, Wu F, Cao L, et al. (2007) Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys, 67(2): 389-96. [DOI:10.1016/j.ijrobp.2006.09.015] [PMID]
31. Minsky BD, Pajak TF, Ginsberg RJ, et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol, 20(5): 1167-74. [DOI:10.1200/JCO.2002.20.5.1167] [PMID]
32. Newaishy GA, Read GA, Duncan W, Kerr GR (1982) Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin Radiol, 33(3): 347-52. [DOI:10.1016/S0009-9260(82)80288-2]
33. Okawa T, Kita M, Tanaka M, Ikeda M (1989) Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys, 17(1): 49-54. [DOI:10.1016/0360-3016(89)90369-6]
34. Sun DR (1989) Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys, 16(2): 329-34. [DOI:10.1016/0360-3016(89)90324-6]
35. Kleinberg L and Forastiere AA (2007) Chemoradiation in the management of esophageal cancer. J Clin Oncol, 25: 4110-17. [DOI:10.1200/JCO.2007.12.0881] [PMID]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Arslan D, Koca T, Kaymak Z, Çevener M, Başaran H. Clinicopathological features and outcomes of 251 patients with esophageal cancer in the Eastern Anatolian Region of Turkey where upper gastrointestinal system tumors are endemic: Single-center data. Int J Radiat Res 2023; 21 (2) :305-310
URL: http://ijrr.com/article-1-4766-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 2 (4-2023) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 50 queries by YEKTAWEB 4660